Bertero L

ORCID: 0000-0001-9887-7668 · 3 papers in corpus
2025
Tumor Immune Microenvironment and Checkpoint Inhibition in Clear Cell Ovarian Carcinoma: Bridging Tumor Biology and Clinical Application in Immunotherapy.
Current issues in molecular biology ·doi:10.3390/cimb47090726

Clear cell ovarian carcinoma is a rare and aggressive histologic subtype of epithelial ovarian cancer, characterized by a chemoresistant phenotype and distinct immunogenomic features. Despite early-phase trials showing a limited response to…

2022
Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers.
Annals of surgical oncology ·doi:10.1245/s10434-022-12353-y

BackgroundThe term uterine smooth muscle tumor of uncertain malignant potential (STUMP) indicates a rare, equivocal entity between benign leiomyomas and leiomyosarcomas. In the present study, we evaluated a comprehensive range of clinical, …

2021
Gut Microbiota and Gynecological Cancers: A Summary of Pathogenetic Mechanisms and Future Directions.
ACS infectious diseases ·doi:10.1021/acsinfecdis.0c00839

Over the past 20 years, important relationships between the microbiota and human health have emerged. A link between alterations of microbiota composition (dysbiosis) and cancer development has been recently demonstrated. In particular, the…